112 related articles for article (PubMed ID: 29648910)
1. Usefulness of positron emission tomography-CT for diagnosis of primary bone marrow lymphoma in children.
Moritani K; Nakano N; Yonezawa S; Ochi F; Tauchi H; Eguchi-Ishimae M; Eguchi M; Ishii E; Nagai K
Pediatr Hematol Oncol; 2018 Mar; 35(2):125-130. PubMed ID: 29648910
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of FDG PET for diagnosis and radiotherapy of the patient with malignant lymphoma involving bone marrow.
Nihashi T; Hayasaka K; Itou T; Sobajima T; Kato R; Ito K; Ito Y; Ishigaki T; Naganawa S
Radiat Med; 2007 Apr; 25(3):130-4. PubMed ID: 17450338
[TBL] [Abstract][Full Text] [Related]
3. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
Pelosi E; Penna D; Douroukas A; Bellò M; Amati A; Arena V; Passera R; Bisi G
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):469-75. PubMed ID: 21150862
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
[TBL] [Abstract][Full Text] [Related]
6. Primary bone marrow lymphoma: A hematological emergency in adults with fever of unknown origin.
Wang HY; Yang CF; Chiou TJ; Gau JP; Chen PM; Tsai CY; Hsu HC; Wang FD; Liu JH; Hsiao LT
Cancer Med; 2018 Aug; 7(8):3713-3721. PubMed ID: 29984910
[TBL] [Abstract][Full Text] [Related]
7. Exploring the role of FDG-PET in the assessment of bone marrow involvement in lymphoma patients as interpreted by qualitative and semiquantitative disease metabolic activity parameter.
Kand PG; Tiwari BP; Basu S; Asopa RV; Nayak UN
Indian J Cancer; 2010; 47(4):380-4. PubMed ID: 21131749
[TBL] [Abstract][Full Text] [Related]
8. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET detection of primary bone marrow large B-cell lymphoma in a patient with hairy cell leukemia.
Paolini R; Bianchini E; D'Andrea E; Al-Nahhas A; Banti E; Muzzio PC; Rubello D
Nucl Med Rev Cent East Eur; 2007; 10(1):23-5. PubMed ID: 17694498
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography findings in patients with lymphoma-associated haemophagocytic syndrome.
Yiu CR; Kao YH; Phipps C; Tan D
Singapore Med J; 2011 Jul; 52(7):e156-9. PubMed ID: 21808950
[TBL] [Abstract][Full Text] [Related]
11. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH
Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868
[TBL] [Abstract][Full Text] [Related]
12. Measuring the "unmeasurable": assessment of bone marrow response to therapy using FDG-PET in patients with lymphoma.
Goudarzi B; Jacene HA; Wahl RL
Acad Radiol; 2010 Sep; 17(9):1175-85. PubMed ID: 20634105
[TBL] [Abstract][Full Text] [Related]
13. [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
Purz S; Mauz-Körholz C; Körholz D; Hasenclever D; Krausse A; Sorge I; Ruschke K; Stiefel M; Amthauer H; Schober O; Kranert WT; Weber WA; Haberkorn U; Hundsdörfer P; Ehlert K; Becker M; Rössler J; Kulozik AE; Sabri O; Kluge R
J Clin Oncol; 2011 Sep; 29(26):3523-8. PubMed ID: 21825262
[TBL] [Abstract][Full Text] [Related]
14. Rosai-Dorfman disease mimics lymphoma on FDG PET/CT in a pediatric patient.
Liu B; Lee NJ; Otero HJ; Servaes S; Zhuang H
Clin Nucl Med; 2014 Feb; 39(2):206-8. PubMed ID: 24152660
[TBL] [Abstract][Full Text] [Related]
15. PET/CT versus bone marrow biopsy in the initial evaluation of bone marrow infiltration in various pediatric malignancies.
Zapata CP; Cuglievan B; Zapata CM; Olavarrieta R; Raskin S; Desai K; De Angulo G
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28901637
[TBL] [Abstract][Full Text] [Related]
16. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
[TBL] [Abstract][Full Text] [Related]
17. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
18. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
19. Importance of Histologic Verification of Positive Positron Emission Tomography/Computed Tomography Findings in the Follow-Up of Patients With Malignant Lymphoma.
Nakayama H; Aisa Y; Ito C; Shimazaki K; Katsumata Y; Hayashi H; Nakazato T
Clin Lymphoma Myeloma Leuk; 2015 Dec; 15(12):753-60. PubMed ID: 26336914
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of bone marrow
Lee JW; Lee SC; Kim HJ; Lee SM
Hell J Nucl Med; 2017; 20(1):17-25. PubMed ID: 28315904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
